December 5, 2024 - 05:16

Fitch Ratings has issued a warning regarding the financial challenges that businesses may face as they anticipate significant shifts in trade policies under the incoming administration of President-elect Donald Trump. With the prospect of renewed tariffs and trade restrictions, companies are urged to reassess their supply chain finance strategies to mitigate potential risks.
The uncertainty surrounding trade relations could lead to increased costs for raw materials and components, impacting profit margins across various industries. Businesses are encouraged to explore innovative financing solutions and optimize their supply chains to maintain competitiveness in this evolving landscape.
Furthermore, companies may need to enhance their liquidity management and consider diversifying their supplier base to reduce dependence on specific markets. As the new administration prepares to implement its trade agenda, the ability to adapt quickly will be crucial for businesses aiming to navigate the complexities of the renewed tariff era effectively.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...